iShares Health Innovation Active ETF (BMED)

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that invests in companies that are involved in healthcare innovation and the use of technology to improve health outcomes. The fund seeks to track the performance of the iShares Genomics Immunology and Healthcare ETF Index.

The index includes companies that are focused on genomics, immunology, telemedicine, health information technology, medical devices, and vaccines. Some of the top holdings of the fund include Illumina Inc., Regeneron Pharmaceuticals Inc., and Thermo Fisher Scientific Inc.

BMED offers investors exposure to a growing industry that is expected to benefit from demographic trends such as aging populations and increasing demand for healthcare services. Additionally, the fund may be of interest to investors who want to participate in the development of new treatments and technologies that could lead to improved health outcomes.